CA3 gene related to beef quality character and application of CA3 gene

By studying the expression of the CA3 gene in beef, the problem of regulating the transformation of beef muscle fiber types was solved, providing a molecular basis for the breeding of high-quality beef and achieving a significant improvement in beef quality traits.

CN118956919APending Publication Date: 2024-11-15SHENYANG AGRI UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410991743.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-23
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing technologies lack effective means to regulate the transformation of beef muscle fiber types, which affects meat quality traits and makes it difficult to achieve the breeding of high-quality meat.

Method used

By screening and studying the carbonic anhydrase (CA3) gene, cloning and detecting its expression level in the longissimus dorsi and psoas major muscles of cattle using RNA-seq technology, and verifying protein expression using Western blot, a molecular basis for regulating beef quality traits was provided.

Benefits of technology

The expression level of the CA3 gene differs significantly from that of different muscle types, providing a molecular basis for screening high-quality beef and significantly improving the quality traits of beef.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118956919A_ABST
    Figure CN118956919A_ABST
Patent Text Reader

Abstract

The embodiment of the invention discloses a CA3 gene related to beef quality characters and application of the CA3 gene. According to the invention, a carbonic anhydrase 3 (CA3) gene related to beef quality characters is separated and cloned from longissimus dorsi tissue of Liaoning white cattle, and the nucleotide sequence of the carbonic anhydrase 3 (CA3) gene is shown as SEQ.ID.NO.1; 1, and the nucleotide sequence of CDS is as shown in SEQ. ID. 2; and the coding amino acid sequence is shown as SEQ. ID. NO.3. Besides, the correlation between the CA3 gene and the beef quality character is detected, that is, the mRNA and protein expression level of the CA3 gene is detected in longissimus dorsi and lumbar major muscle tissues, and the result shows that the expression level of the CA3 gene in the lumbar major muscle (slow muscle) is obviously higher than that in the longissimus dorsi (fast muscle). The invention provides a molecular basis for breeding of beef quality traits.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The embodiments of the present invention relate to the field of genetic engineering technology, and specifically to a CA3 gene related to beef quality traits and an application thereof. Background Art

[0002] With the improvement of people's living standards, high-quality meat has gradually appeared on people's tables. Meat quality mainly includes meat color, pH, tenderness, drip loss, etc. In recent years, a large number of studies have shown that the number, size and type of muscle fibers affect meat quality. Muscle fibers are generally divided into two types according to their contraction and metabolic characteristics, namely type I (slow oxidation type) and type II (fast glycolytic type). Slow muscle fibers are also called red muscles, and fast muscle fibers are also called white muscles. Now, four types of muscle fibers have been identified in various livestock such as pigs and cattle, namely slow oxidation type (MYHⅠ), fast oxidation type (MYHⅡa), intermediate type (MYHⅡx) and fast glycolytic type (MYHⅡb). Compared with fast glycolytic muscle fibers, slow oxidation muscle fibers have high mitochondrial content, low glycogen concentration and glycolytic enzyme activity. It is reported that pigs with a higher ratio of type I to type IIa fibers have lower drip loss, lower meat brightness and higher muscle pH 45 minutes after slaughter, and the more type IIB fibers, the worse the muscle quality and the lower the lean meat yield. Increasing the proportion of type I fibers in beef increases the myoglobin content of the meat, and the proportion of type I fibers is also related to the brightness, pH value and drip loss of the meat. Therefore, the metabolic differences between different fiber types have a certain impact on meat quality.

[0003] The total number of muscle fibers is only related to the proliferation of muscle cells during the fetal period. It is generally believed that after an animal is born, the total number of muscle fibers remains basically unchanged and only transforms between different types of muscle fibers. In recent years, with the rapid development of high-throughput sequencing and bioinformatics, it has been found that many genes and non-coding RNAs such as miRNA and circRNA can also affect the growth and development of muscle fibers and the transformation process by regulating protein expression, thereby having an important impact on meat quality. Therefore, screening out a gene that can affect the transformation of cattle muscle fiber types to achieve the regulation of beef quality traits is of great significance for the breeding of cattle breeds with high-quality meat traits. Summary of the invention

[0004] In the past few decades, many genes that affect muscle fiber type conversion have been reported. Recently, the applicant screened the carbonic anhydrase (CA3) gene through RNA-seq technology as a candidate gene that may affect muscle fiber type conversion. CA3 is an abundant muscle protein that promotes CO2 diffusion and is involved in H + and HCO3 -It plays an important role in various processes of transport and is a key enzyme that mediates the reversible hydration of carbon dioxide. It plays an important role in gas transport, acid-base regulation, bone resorption and calcification, ion transport and various secretory functions in different tissues. In neuromuscular, CA3 is a well-established biomarker routinely used in muscle pathology, making it an ideal candidate for assessing potential fiber type transitions during muscle aging. CA3 is mainly present in the cytoplasmic part of type I fibers in animals such as humans, and can promote the transformation of fast muscles to slow muscles, which also makes it an ideal marker for studying fiber type transfer and muscle adaptation. However, there is little research on the CA3 gene in cattle muscle fiber types. Therefore, further research on the correlation analysis of CA3 expression levels and beef quality traits can lay a theoretical foundation for future applications in molecular breeding.

[0005] To this end, an embodiment of the present invention provides a CA3 gene related to beef quality traits and its application.

[0006] In order to achieve the above purpose, the embodiment of the present invention provides the following technical solutions:

[0007] According to the first aspect of an embodiment of the present invention, the present invention provides a CA3 gene related to beef quality traits, the nucleotide sequence of the CA3 gene is shown in SEQ.ID.NO.1, the CDS nucleotide sequence is shown in SEQ.ID.NO.2, and the encoded amino acid sequence is shown in SEQ.ID.NO.3.

[0008] According to a second aspect of an embodiment of the present invention, the present invention provides the use of the CA3 gene as described above in identifying beef quality traits.

[0009] Furthermore, the application is related to muscle fiber type conversion.

[0010] Further, the following steps are included:

[0011] (1) Total RNA was extracted from the longissimus dorsi and psoas major muscles of cattle, and RT-PCR reaction was performed using the total RNA as a template;

[0012] (2) performing real-time quantitative PCR using the RT-PCR product of step (1) as a template;

[0013] (3) Proteins were extracted from the longissimus dorsi and psoas major muscles of cattle and verified by western-blot.

[0014] Furthermore, in step (2), the primers for real-time quantitative PCR are a forward primer and a reverse primer, the forward primer is shown as SEQ.ID.NO.4, and the reverse primer is shown as SEQ.ID.NO.5.

[0015] According to a third aspect of an embodiment of the present invention, the present invention provides the use of the CA3 gene as described above in cattle genetic improvement.

[0016] The embodiments of the present invention have the following advantages:

[0017] The present invention separates and clones the carbonic anhydrase 3 (CA3) gene related to beef quality traits from the longissimus dorsi muscle tissue of Liaoyu white cattle. The length of the CA3 gene is 1703bp, including 783bp CDS, 29bp 5'UTR and 891bp 3'UTR. The nucleotide sequence is shown in SEQ.ID.NO.1; the CDS nucleotide sequence is shown in SEQ.ID.NO.2; and the encoded amino acid sequence is shown in SEQ.ID.NO.3. In addition, the correlation between the CA3 gene and the beef quality traits is detected, that is, the mRNA and protein expression levels of the CA3 gene are detected in the longissimus dorsi and psoas muscle tissues. The results show that the expression level of the CA3 gene in the psoas major (slow muscle) is significantly higher than that in the longissimus dorsi (fast muscle). The present invention provides a molecular basis for the selection and breeding of beef quality traits. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] In order to more clearly illustrate the implementation methods of the present invention or the technical solutions in the prior art, the following briefly introduces the drawings required for the implementation methods or the description of the prior art. Obviously, the drawings in the following description are only exemplary, and for ordinary technicians in this field, other implementation drawings can be derived from the provided drawings without creative work.

[0019] Figure 1 This is the electrophoresis pattern of the amplified CA3 gene CDS provided by the present invention; in the figure: Marker: DNA molecular weight standard (DL2000: 2000, 1000, 750, 500, 250 and 100), and the lanes in the figure are the amplified fragments of the CA3 gene CDS region.

[0020] Figure 2 This is the electrophoresis pattern of the amplified CA3 gene 3'UTR fragment provided by the present invention; in the figure: Marker: DNA molecular weight standard (DL2000: 2000, 1000, 750, 500, 250 and 100), and the lanes in the figure are the amplified fragments of the 3'UTR region.

[0021] Figure 3 This is the electrophoresis pattern of the amplified CA3 gene 5'UTR fragment provided by the present invention; in the figure: Marker: DNA molecular weight standard (DL2000: 2000, 1000, 750, 500, 250 and 100), and the lanes in the figure are the amplified fragments of the 5'UTR region.

[0022] Figure 4 The statistical results of CA3 gene expression levels of the longissimus dorsi and psoas major muscles provided by the present invention; LD: longissimus dorsi, PM: psoas major, N=8, ** indicates P<0.01.

[0023] Figure 5 The statistical results of the protein expression of CA3 gene in the adipose tissue of longissimus dorsi and psoas major provided by the present invention; LD: longissimus dorsi, PM: psoas major, N=8, ** indicates P<0.01. DETAILED DESCRIPTION

[0024] The following is a description of the implementation of the present invention by specific embodiments. People familiar with the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0025] First, according to the partial mRNA sequence of cattle CA3 gene in NCBI database (NM_001034437), the 5' and 3' UTR regions of CA3 gene were cloned and sequenced using HiScript-TS 5' / 3' RACE technology. In addition, a pair of primers were designed to clone and sequence the CDS region of CA3 gene. After splicing all the sequenced fragments, the full-length cDNA sequence of CA3 gene was obtained, and its nucleotide sequence is shown in SEQ.ID.NO.1, wherein the CDS nucleotide sequence is shown in SEQ.ID.NO.2, and the encoded amino acid sequence is shown in SEQ.ID.NO.3.

[0026] Total RNA was extracted from the longissimus dorsi (fast muscle) and psoas major (slow muscle) of 8 individuals, and then the expression levels of the CA3 gene in the two muscle samples were detected using quantitative primers. The quantitative results showed that the expression level of the CA3 gene in the psoas major was significantly higher than that in the longissimus dorsi.

[0027] At the same time, the longissimus dorsi (fast muscle) and psoas major (slow muscle) of 8 individuals were selected for total protein extraction, and then the expression level of CA3 gene in the two muscle samples was verified by western blot experiment. The results showed that the expression level of CA3 gene in psoas major was significantly higher than that in longissimus dorsi, indicating that CA3 gene is a key gene that can be applied to the selection of slow muscle individuals.

[0028] Table 1 Primer sequences

[0029]

[0030] Example 1

[0031] 1. Cloning and sequencing of the full-length cDNA sequence of CA3 gene

[0032] 1) Muscle tissue sample collection and total RNA extraction

[0033] The longissimus dorsi and psoas major muscles of Liaoyu white cattle were collected and immediately frozen in liquid nitrogen, then transported back to the laboratory and stored at -80°C. Total RNA from muscle tissue was extracted using the TRIZOL method and stored at -80°C.

[0034] 2) cDNA synthesis

[0035] RT-PCR reaction was performed using the PrimeScriptTM RT MasterMix kit from TaKaRa using total muscle RNA as template.

[0036] Reaction system: 20 μl in total, including 4 μl 5× PrimeScript RT MasterMix, 1 μg RNA and RNaseFree ddH2O to make up to 20 μl;

[0037] Reaction procedure: 37°C for 15 min; 85°C for 5 s.

[0038] 3) CA3 gene CDS amplification, cloning and sequencing

[0039] ① Primer premier 5.0 was used to design amplification primers. The sequences of primers used to clone the CDS region of the CA3 gene are shown in Table 1. Using cDNA as a template, PCR amplification was performed using 2× TransStart Fast Pfu Fly PCR Super Mix.

[0040] ② Reaction system: 10 μl in total, including 1 μl cDNA, 0.2 μl upstream and downstream primers, 5 μl 2×TransStartFastPfuFlyPCR SuperMix and 3.6 μl ddH2O.

[0041] ③ Reaction program: 98℃1min; 30 cycles including 98℃10s, annealing temperature for 5s, 72℃1min; 72℃1min.

[0042] ④ Detection of amplified products: PCR products were detected by 1% agarose gel electrophoresis ( Figure 1), cut out the target fragment from the gel and purify it using a gel recovery kit; clone the purified target fragment into the pGEM-T vector, and transform the ligation product into DH5α; pick a single clone and inoculate it into 1 ml of LB culture medium containing 1000 μl of ampicillin (Amp), and culture it in a shaking incubator at 37°C for about 16 hours before sending it to Shanghai Sangon Biotechnology Co., Ltd. for sequencing.

[0043] 4) Amplification, cloning and sequencing of 5'UTR and 3'UTR of CA3 gene

[0044] ①RACE-Ready cDNA: RACE-Ready cDNA was synthesized using muscle RNA as a template using the HiScript-TS5' / 3'RACE kit.

[0045] ②5'RACE amplification reaction system: 1.0μl RNA, 2μl 5'CDS Primer, 2μl dNTPMix, RNase-free ddH2O to 13μl.

[0046] ③3'RACE amplification reaction system: 1.0μl RNA, 2μl 3'CDS Primer, 2μl dNTPMix, RNase-free ddH2O to 14μl.

[0047] ④5'RACE and 3'RACE amplification reaction procedures: 72℃3min; on ice for 2min.

[0048] ⑤ Reverse transcription reaction system: 5'RACE and 3'RACE amplification products, 4μl 5×FS Buffer, 2μl 10×Enzyme Mix, 1μl 5'TS Oligo.

[0049] ⑥Reaction procedure: 42℃ for 90 min, 70℃ for 15 min, 4℃ hold.

[0050] ⑦5'RACE and 3'RACE cDNA end rapid amplification reaction system: a total of 50μl, including 2.5μl 5' or 3'RACE-Ready cDNA, 1μl 5' or 3'GSP (10μM), 5μl 10×Universal Primer Mix (UPM), 25μl 2×PCRMix and 16.5μl ddH2O.

[0051] ⑧Reaction program: 98℃1min; 30 cycles including 98℃10s, 68℃15s, 72℃3min; 72℃5min, 4℃hold.

[0052] ⑨ Detection of amplified products: After the PCR products were detected by 1% agarose gel electrophoresis, the target fragment was cut out of the gel and purified using a gel recovery kit; the purified target fragment was cloned into the pGEM-T vector, and the ligation product was transformed into DH5α; a single clone was picked and inoculated into 1 ml of LB culture medium containing 1000 μl of ampicillin (Amp), and then cultured at 37°C in a shaking incubator for about 16 hours and then sent to Shanghai Shenggong Biotechnology Co., Ltd. for sequencing ( Figure 2 and Figure 3 ).

[0053] After splicing all the sequenced fragments, the full-length cDNA sequence of the CA3 gene was obtained, and its nucleotide sequence is shown in SEQ.ID.NO.1, wherein the CDS nucleotide sequence is shown in SEQ.ID.NO.2, and the encoded amino acid sequence is shown in SEQ.ID.NO.3.

[0054] Example 2

[0055] Detection of CA3 gene expression levels in different tissues

[0056] 1) Sample collection

[0057] The longissimus dorsi and psoas major muscle tissues were collected from 8 Liaoyu white cattle. The total RNA of muscle tissues was extracted from the longissimus dorsi and psoas major muscles using the TRIZOL method, and the RNA was stored at -80℃ for future use.

[0058] 2) cDNA synthesis

[0059] RT-PCR reaction was performed using total muscle RNA as template using PrimeScriptTM RT Master Mix kit from TaKaRa.

[0060] Reaction system: 20 μL in total, including 4 μL 5× PrimeScript RT MasterMix, 1 μg RNA and RNaseFree ddH2O to make up to 20 μL;

[0061] Reaction procedure: 37°C for 15 min; 85°C for 5 s.

[0062] 3) Detection of CA3 gene mRNA levels in different tissues

[0063] Real-time PCR was used to detect the expression level of CA3 gene mRNA.

[0064] The system is 20 μl, including 10 μl qPCR Green Master Mix (Without ROX), 0.25 μl upstream and downstream primers (10 μM), 2.0 μl template cDNA, and 7.5 μl sterile distilled water.

[0065] The reaction program included: pre-denaturation: 95°C for 5 min; 40 cycles (95°C, 10 s; 60°C, 30 s); melting curve: 95°C for 15 s; 60°C for 1 min; 95°C for 15 s.

[0066] The PCR reaction of all samples was repeated three times, and the relative expression level of genes was calculated using the △△Ct method, and the β-actin gene was used as the internal reference gene for relative expression level correction. Graphpad 8 was used for plotting, and the independent t-test was used to compare the significance of differences between different groups. The results of gene expression level detection showed that the mRNA level of CA3 gene in psoas major muscle was significantly higher than that in longissimus dorsi muscle ( Figure 4 ).

[0067] 4) Protein extraction

[0068] 0.1 g muscle tissue samples were placed in 2 ml centrifuge tubes and lysed with RIPA lysis buffer containing PMSF (Biyuntian Biotechnology, Shanghai, China). The lysate was centrifuged at 4 °C, 12,000 × g for 15 min, and the supernatant was collected into a new 1.5 ml centrifuge tube. The protein concentration was determined using a BCA kit (Sangon Biotechnology, Shanghai, China). Each sample was denatured by adding 5 × SDS and boiling at 95 °C for 10 min and stored at -20 °C.

[0069] Western blot experiments

[0070] The protein samples were added to FuturePAGETM protein gel and separated at 160V for 40 minutes. After electrophoresis, the proteins were transferred to PVDF membranes (Millpore, Corp, Bedford, MA). The PVDF membranes were blocked with protein-free fast blocking buffer (Shanghai EpiZyme Biotechnology, Shanghai, China) for 15 minutes, washed 3 times with TBST, and incubated at room temperature for 2 hours with primary antibodies of CA3 (Proteintech, Wuhan, China) and Tubulin (Sigma-Aldrich, MO, USA). Then washed three times with TBST, incubated at room temperature for 1.5 hours with secondary antibodies (Proteintech, Wuhan, China), and then washed three times with TBST. Finally, protein bands were displayed using an ECL chemiluminescence kit (Biyuntian Biotechnology, Shanghai, China). The abundance level of each protein was quantified using ImageJ software (National Institutes of Health, Bethesda, MD, USA). Protein expression levels were normalized to the expression level of Tubulin. The results showed that the protein expression level of CA3 gene in psoas major muscle was significantly higher than that in longissimus dorsi muscle ( Figure 5 ).

[0071] In summary, the CA3 gene can be used as a key gene for screening beef quality.

[0072] Although the present invention has been described in detail above by general description and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements can be made to the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all belong to the scope of protection claimed by the present invention.

[0073]

[0074]

[0075]

[0076]

[0077]

[0078]

Claims

1. A CA3 gene associated with beef quality traits, characterized in that: The nucleotide sequence of the CA3 gene is shown in SEQ.ID.NO.1, the CDS nucleotide sequence is shown in SEQ.ID.NO.2, and the encoded amino acid sequence is shown in SEQ.ID.NO.

3.

2. Use of the CA3 gene according to claim 1 in identifying beef quality traits.

3. The use according to claim 2, characterized in that: The application is related to muscle fiber type conversion.

4. The use according to claim 2, characterized in that: The following steps are involved: (1) Total RNA was extracted from the longissimus dorsi and psoas major muscles of cattle, and RT-PCR reaction was performed using the total RNA as a template; (2) performing real-time quantitative PCR using the RT-PCR product of step (1) as a template; (3) Proteins were extracted from the longissimus dorsi and psoas major muscles of cattle and verified by western blot.

5. The use according to claim 4, characterized in that: In step (2), the primers for real-time quantitative PCR are a forward primer and a reverse primer, the forward primer is shown as SEQ.ID.NO.4, and the reverse primer is shown as SEQ.ID.NO.

5.

6. Use of the CA3 gene according to claim 1 in cattle genetic improvement.